rs35304565

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_003327.4(TNFRSF4):​c.28C>T​(p.Arg10Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00773 in 1,585,918 control chromosomes in the GnomAD database, including 100 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R10H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0053 ( 5 hom., cov: 33)
Exomes 𝑓: 0.0080 ( 95 hom. )

Consequence

TNFRSF4
NM_003327.4 missense

Scores

5
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.340

Publications

10 publications found
Variant links:
Genes affected
TNFRSF4 (HGNC:11918): (TNF receptor superfamily member 4) The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor has been shown to activate NF-kappaB through its interaction with adaptor proteins TRAF2 and TRAF5. Knockout studies in mice suggested that this receptor promotes the expression of apoptosis inhibitors BCL2 and BCL2lL1/BCL2-XL, and thus suppresses apoptosis. The knockout studies also suggested the roles of this receptor in CD4+ T cell response, as well as in T cell-dependent B cell proliferation and differentiation. [provided by RefSeq, Jul 2008]
TNFRSF4 Gene-Disease associations (from GenCC):
  • combined immunodeficiency due to OX40 deficiency
    Inheritance: AR, Unknown Classification: SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0057964325).
BP6
Variant 1-1214100-G-A is Benign according to our data. Variant chr1-1214100-G-A is described in ClinVar as Benign. ClinVar VariationId is 474794.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00527 (803/152330) while in subpopulation SAS AF = 0.0193 (93/4822). AF 95% confidence interval is 0.0161. There are 5 homozygotes in GnomAd4. There are 388 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNFRSF4NM_003327.4 linkc.28C>T p.Arg10Cys missense_variant Exon 1 of 7 ENST00000379236.4 NP_003318.1 P43489
TNFRSF4NM_001410709.1 linkc.28C>T p.Arg10Cys missense_variant Exon 1 of 6 NP_001397638.1
TNFRSF4XR_007063145.1 linkn.54C>T non_coding_transcript_exon_variant Exon 1 of 3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNFRSF4ENST00000379236.4 linkc.28C>T p.Arg10Cys missense_variant Exon 1 of 7 1 NM_003327.4 ENSP00000368538.3 P43489

Frequencies

GnomAD3 genomes
AF:
0.00529
AC:
805
AN:
152212
Hom.:
5
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00181
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00562
Gnomad ASJ
AF:
0.00778
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0191
Gnomad FIN
AF:
0.00396
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00679
Gnomad OTH
AF:
0.00812
GnomAD2 exomes
AF:
0.00854
AC:
1757
AN:
205672
AF XY:
0.00985
show subpopulations
Gnomad AFR exome
AF:
0.00206
Gnomad AMR exome
AF:
0.00352
Gnomad ASJ exome
AF:
0.00848
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00511
Gnomad NFE exome
AF:
0.00796
Gnomad OTH exome
AF:
0.00841
GnomAD4 exome
AF:
0.00799
AC:
11452
AN:
1433588
Hom.:
95
Cov.:
34
AF XY:
0.00846
AC XY:
6023
AN XY:
711812
show subpopulations
African (AFR)
AF:
0.00154
AC:
51
AN:
33038
American (AMR)
AF:
0.00335
AC:
141
AN:
42130
Ashkenazi Jewish (ASJ)
AF:
0.00929
AC:
239
AN:
25720
East Asian (EAS)
AF:
0.0000514
AC:
2
AN:
38874
South Asian (SAS)
AF:
0.0244
AC:
2035
AN:
83548
European-Finnish (FIN)
AF:
0.00580
AC:
251
AN:
43312
Middle Eastern (MID)
AF:
0.0213
AC:
90
AN:
4234
European-Non Finnish (NFE)
AF:
0.00736
AC:
8120
AN:
1103394
Other (OTH)
AF:
0.00881
AC:
523
AN:
59338
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
663
1326
1989
2652
3315
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
320
640
960
1280
1600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00527
AC:
803
AN:
152330
Hom.:
5
Cov.:
33
AF XY:
0.00521
AC XY:
388
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.00180
AC:
75
AN:
41582
American (AMR)
AF:
0.00562
AC:
86
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00778
AC:
27
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.0193
AC:
93
AN:
4822
European-Finnish (FIN)
AF:
0.00396
AC:
42
AN:
10618
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00678
AC:
461
AN:
68018
Other (OTH)
AF:
0.00803
AC:
17
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
41
83
124
166
207
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00712
Hom.:
4
Bravo
AF:
0.00500
TwinsUK
AF:
0.00755
AC:
28
ALSPAC
AF:
0.00519
AC:
20
ESP6500AA
AF:
0.00116
AC:
5
ESP6500EA
AF:
0.00736
AC:
62
ExAC
AF:
0.00785
AC:
932
Asia WGS
AF:
0.00722
AC:
25
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Combined immunodeficiency due to OX40 deficiency Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

TNFRSF4-related disorder Benign:1
Oct 02, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.34
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
17
DANN
Uncertain
0.98
DEOGEN2
Benign
0.39
T
Eigen
Benign
-0.54
Eigen_PC
Benign
-0.71
FATHMM_MKL
Benign
0.042
N
LIST_S2
Benign
0.53
T
MetaRNN
Benign
0.0058
T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
0.90
L
PhyloP100
-0.34
PrimateAI
Benign
0.45
T
PROVEAN
Uncertain
-2.6
D
REVEL
Benign
0.12
Sift
Uncertain
0.0070
D
Sift4G
Uncertain
0.011
D
Polyphen
0.98
D
Vest4
0.16
MVP
0.62
MPC
0.20
ClinPred
0.016
T
GERP RS
2.2
PromoterAI
-0.058
Neutral
Varity_R
0.17
gMVP
0.84
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35304565; hg19: chr1-1149480; COSMIC: COSV55420573; COSMIC: COSV55420573; API